Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1996516 | 0.94 | LMNA (0.50) | LMNAALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL14808198 | 0.92 | LMNA (0.65) | LMNAALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL3972497 | 0.91 | LMNA (0.48) | LMNAALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL3964955 | 0.91 | LMNA (0.48) | LMNAALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL9058714 | 0.87 | ALDH1A1 (0.50) | LMNAALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL9615568 | 0.86 | ALDH1A1 (0.54) | LMNAALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL7594004 | 0.86 | LMNA (0.43) | LMNAALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL20124078 | 0.84 | ALDH1A1 (0.65) | LMNAALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL11689620 | 0.84 | LMNA (0.42) | LMNAALDH1A1TDP1CYP3A4TSHR | |
| SCHEMBL17526511 | 0.84 | ALDH1A1 (0.46) | LMNAALDH1A1TDP1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116183797-A | Method for distinguishing milk with different fat content types | 内蒙古伊利实业集团股份有限公司 | 2023-05-30 | — | — | CN | disclosed |
| US-9145528-B2 | Methods of preparing oil compositions for fuel refining | SAPPHIRE ENERGY, INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-20120116138-A1 | METHODS OF PREPARING OIL COMPOSITIONS FOR FUEL REFINING | SAPPHIRE ENERGY, INC (US) | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120116138-A1 | METHODS OF PREPARING OIL COMPOSITIONS FOR FUEL REFINING | FASN, LIPC, ALOX15 | LMNA 1655/4885ALDH1A1 1467/4885TDP1 2864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.